Atlas Trials

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT04150692 · WITHDRAWN

Trial details

NCT number
NCT04150692
Sponsor
Washington University School of Medicine
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2021-01-08
Primary completion
2026-03-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.